Literature DB >> 12081601

Occult hepatitis B virus infection and its clinical implications.

Ke-Qin Hu1.   

Abstract

Occult hepatitis B virus (HBV) infection is characterized by presence of HBV infection with undetectable hepatitis B surface antigen (HBsAg). Serum HBV level is usually less than 104 copies/mL in these patients. Diagnosis of occult HBV infection requires sensitive HBV-DNA PCR assay. Several possibilities have been hypothesized as the mechanisms of occult HBV infection. These include: (i) mutations of HBV-DNA sequence; (ii) integration of HBV-DNA into host's chromosomes; (iii) infection of peripheral blood mononuclear cells by HBV; (iv) formation of HBV-containing immune complex; (v) altered host immune response; and (vi) interference of HBV by other viruses. The precise prevalence of occult HBV infection remains to be defined. The clinical implications of occult HBV infection involve different clinical aspects. First of all, occult HBV infection harbours potential risk of HBV transmission through blood transfusion, haemodialysis, and organ transplantation. Second, it may serve as the cause of cryptogenic liver disease, contribute to acute exacerbation of chronic hepatitis B, or even fulminant hepatitis. Third, it is associated with development of hepatocellular carcinoma. Fourth, it may affect disease progression and treatment response of chronic hepatitis C. Most of the previous studies utilized retrospective observation without control groups, and lacked direct association of occult HBV infection with specific pathological changes and disease progression. Highly sensitive, quantitative, and functional molecular analyses of HBV, combined with a well-designed prospective clinical assessment will provide the best approach for the future study of occult HBV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12081601     DOI: 10.1046/j.1365-2893.2002.00344.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  67 in total

1.  Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients?

Authors:  Mehmet Kanbay; Gurden Gur; Ali Akcay; Haldun Selcuk; Ugur Yilmaz; Hande Arslan; Sedat Boyacioglu; Fatma Nurhan Ozdemir
Journal:  Dig Dis Sci       Date:  2006-09-15       Impact factor: 3.199

2.  Hepatitis B virus inhibits the expression of complement C3 and C4, in vitro and in vivo.

Authors:  Chengliang Zhu; Hui Song; Fengxia Xu; Wei Yi; Fang Liu; Xinghui Liu
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

3.  Prevalence of occult HBV infection in haemodialysis patients with chronic HCV.

Authors:  Vedat Goral; Hamza Ozkul; Selahattin Tekes; Dede Sit; Ali Kemal Kadiroglu
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis.

Authors:  Hanan Foaud; Sahar Maklad; Faten Mahmoud; Hanaa El-Karaksy
Journal:  Infection       Date:  2015-02-10       Impact factor: 3.553

5.  Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC.

Authors:  Hiroji Shinkawa; Takuya Nakai; Akihiro Tamori; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Masao Ogawa; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Kazuhiro Hirohashi; Kenichi Wakasa; Shoji Kubo
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

Review 6.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

Review 7.  Current hepatitis B virus infection situation in Indonesia and its genetic diversity.

Authors:  Maria Inge Lusida; Yoshihiko Yano
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

8.  Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion.

Authors:  Rajesh Panigrahi; Avik Biswas; Sibnarayan Datta; Arup Banerjee; Partha K Chandra; Pradip K Mahapatra; Bharat Patnaik; Sekhar Chakrabarti; Runu Chakravarty
Journal:  Virol J       Date:  2010-08-27       Impact factor: 4.099

9.  Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.

Authors:  C M Martin; J A Welge; N J Shire; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2009-11-02       Impact factor: 3.728

10.  Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals.

Authors:  Christina M Martin; Jeffrey A Welge; Norah J Shire; Mohamed T Shata; Kenneth E Sherman; Jason T Blackard
Journal:  Cytokine       Date:  2009-07-21       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.